BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35250308)

  • 1. Effects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-Study.
    Wilke T; Weisser B; Predel HG; Schmieder R; Wassmann S; Gillessen A; Blettenberg J; Maywald U; Randerath O; Mueller S; Böhm M
    Integr Blood Press Control; 2022; 15():11-21. PubMed ID: 35250308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Persistence to Medication, Decreased Cardiovascular Events and Reduced All-Cause Mortality in Hypertensive Patients With Use of Single-Pill Combinations: Results From the START-Study.
    Schmieder RE; Wassmann S; Predel HG; Weisser B; Blettenberg J; Gillessen A; Randerath O; Mevius A; Wilke T; Böhm M
    Hypertension; 2023 May; 80(5):1127-1135. PubMed ID: 36987918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
    Machnicki G; Ong SH; Chen W; Wei ZJ; Kahler KH
    Curr Med Res Opin; 2015 Dec; 31(12):2287-96. PubMed ID: 26397178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Retrospective Observational Real-Word Analysis of the Adherence, Healthcare Resource Consumption and Costs in Patients Treated with Bisoprolol/Perindopril as Single-Pill or Free Combination.
    Masi S; Kobalava Z; Veronesi C; Giacomini E; Degli Esposti L; Tsioufis K
    Adv Ther; 2024 Jan; 41(1):182-197. PubMed ID: 37864626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.
    Weisser B; Predel HG; Gillessen A; Hacke C; Vor dem Esche J; Rippin G; Noetel A; Randerath O
    High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):157-164. PubMed ID: 32219670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A real-world analysis of outcomes and healthcare costs of patients on perindopril/indapamide/amlodipine single-pill vs. multiple-pill combination in Italy.
    Snyman JR; Bortolotto LA; Degli Esposti L; Jayagopal PB; Konradi AO; Perrone V; Borghi C
    J Hypertens; 2024 Jan; 42(1):136-142. PubMed ID: 37728093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O; Andrews LM; Wang L; Xie L
    J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of single-pill combination of indapamide and amlodipine in the treatment of arterial hypertension in the Polish setting.
    Kawalec P; Holko P; Stawowczyk E; Borowiec Ł; Filipiak KJ
    Kardiol Pol; 2015; 73(9):768-80. PubMed ID: 25987296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: A randomized controlled trial.
    Sung J; Ahn KT; Cho BR; Lee SY; Kim BJ; Kim DK; Park JI; Lee WS
    Clin Transl Sci; 2021 May; 14(3):1185-1192. PubMed ID: 33503302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy.
    Xie L; Frech-Tamas F; Marrett E; Baser O
    Curr Med Res Opin; 2014 Dec; 30(12):2415-22. PubMed ID: 25222764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cardiovascular single pill combinations compared with identical multi-pill therapies on healthcare cost and utilization in Germany.
    Wilke T; Weisser B; Predel HG; Schmieder RE; Wassmann S; Gillessen A; Blettenberg J; Maywald U; Randerath O; Müller S; Böhm M
    J Comp Eff Res; 2022 Apr; 11(6):411-422. PubMed ID: 35315281
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of combination drugs on antihypertensive medication adherence in a real-world setting: a Korean Nationwide Study.
    Kim SJ; Kwon OD; Cho B; Oh SW; Lee CM; Choi HC
    BMJ Open; 2019 Jun; 9(6):e029862. PubMed ID: 31230034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of single-pill combinations versus free-equivalent combinations on adherence and persistence in patients with hypertension and dyslipidemia: a systematic literature review and meta-analysis.
    Kengne AP; Brière JB; Le Nouveau P; Kodjamanova P; Atanasov P; Kochoedo M; Irfan O; Khan ZM
    Expert Rev Pharmacoecon Outcomes Res; 2023 Dec; ():1-11. PubMed ID: 38088763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
    Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
    Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of single pill combinations in the treatment of arterial hypertension in Poland: The current practice and guidelines, the impact on reimbursement spending and patient co-payment.
    Czech M; Boguslawski S; Smaga A; Filipiak KJ
    Cardiol J; 2022; 29(3):405-412. PubMed ID: 35578761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees.
    Chapman RH; Yeaw J; Roberts CS
    BMC Cardiovasc Disord; 2010 Jun; 10():29. PubMed ID: 20565779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy.
    Malesker MA; Hilleman DE
    Manag Care; 2010 Jul; 19(7):36-42. PubMed ID: 20672530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of the single-pill combination of aliskiren 300 mg/amlodipine 10 mg in hypertensive patients not controlled by olmesartan 40 mg/amlodipine 10 mg.
    Axthelm C; Sieder C; Meister F; Kaiser E
    Curr Med Res Opin; 2012 Jan; 28(1):69-78. PubMed ID: 22117838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. China STudy of valsartan/amlodipine fixed-dose combination-bAsed long-Term blood pressUre management in HypertenSive patients: a one-year registry (China STATUS III).
    Huo Y; Gu Y; Ma G; Guo J; Xiong L; Luo Z; Xie J; Li W; Zhao J; Yan X; Liu W; Xu Y; Bao X; Zhao L; Yang M; Wang B; Iii Study Group TCS
    Curr Med Res Opin; 2019 Aug; 35(8):1441-1449. PubMed ID: 30880492
    [No Abstract]   [Full Text] [Related]  

  • 20. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
    Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
    Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.